Literature DB >> 12667664

A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis.

Nathalie Arbour1, Andreas Holz, Jack C Sipe, Denise Naniche, John S Romine, Jack Zyroff, Michael B A Oldstone.   

Abstract

We used a flow cytometry assay to measure proliferation and cytokine production of self-antigen-specific T cells in individual patients during the clinical course of multiple sclerosis (MS). Myelin-associated oligodendrocytic basic protein (MOBP) was selected for proof of principles in the assay, along with myelin basic protein (MBP) to assess specific activated T cells in 10 MS patients over an 18-month period, in parallel with brain magnetic resonance imaging (MRI) scans and clinical rating scale. A positive correlation occurred between antigen-specific T cell proliferation and interferon-gamma production with clinical relapses and MRI lesion activity that was absent when the same patients were in remission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667664      PMCID: PMC5050032          DOI: 10.1016/s0165-5728(03)00080-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  64 in total

Review 1.  Autoimmune disease: why and where it occurs.

Authors:  P Marrack; J Kappler; B L Kotzin
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.

Authors:  W E Biddison; W W Cruikshank; D M Center; C M Pelfrey; D D Taub; R V Turner
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Rapid flow cytometric method for measuring lymphocyte subset activation.

Authors:  V C Maino; M A Suni; J J Ruitenberg
Journal:  Cytometry       Date:  1995-06-01

5.  Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.

Authors:  Nitin J Karandikar; Michael P Crawford; Xiao Yan; Robert B Ratts; Jason M Brenchley; David R Ambrozak; Amy E Lovett-Racke; Elliot M Frohman; Peter Stastny; Daniel C Douek; Richard A Koup; Michael K Racke
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase for BALB/c and SJL mice.

Authors:  J A Määttä; M S Käldman; S Sakoda; A A Salmi; A E Hinkkanen
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

7.  Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity.

Authors:  Z Jingwu; R Medaer; G A Hashim; Y Chin; E van den Berg-Loonen; J C Raus
Journal:  Ann Neurol       Date:  1992-09       Impact factor: 10.422

8.  Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI.

Authors:  J Oger; L F Kastrukoff; D K Li; D W Paty
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

9.  Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Authors:  P Rieckmann; M Albrecht; B Kitze; T Weber; H Tumani; A Broocks; W Lüer; A Helwig; S Poser
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

10.  T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions.

Authors:  K W Wucherpfennig; J Newcombe; H Li; C Keddy; M L Cuzner; D A Hafler
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Stage-specific immune dysregulation in multiple sclerosis.

Authors:  Benjamin M Segal
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

2.  B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.

Authors:  Raphael Schneider; Alma Nazlie Mohebiany; Igal Ifergan; Diane Beauseigle; Pierre Duquette; Alexandre Prat; Nathalie Arbour
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

3.  Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis.

Authors:  Talita Siara Almeida Baptista; Laura Esteves Petersen; Julia K Molina; Tatiana de Nardi; Andréa Wieck; Aline do Prado; Deise Marcela Piovesan; Mauro Keisermann; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2017-06-27       Impact factor: 2.980

4.  Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis.

Authors:  Ethan J Baughman; Jason P Mendoza; Sterling B Ortega; Chris L Ayers; Benjamin M Greenberg; Elliot M Frohman; Nitin J Karandikar
Journal:  J Autoimmun       Date:  2011-01-22       Impact factor: 7.094

5.  Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.

Authors:  Marina Zafranskaya; Patrick Oschmann; Rosel Engel; Andreas Weishaupt; Johannes M van Noort; Hassan Jomaa; Matthias Eberl
Journal:  Immunology       Date:  2006-12-18       Impact factor: 7.397

6.  MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.

Authors:  Samantha Jilek; Myriam Schluep; Giuseppe Pantaleo; Renaud A Du Pasquier
Journal:  Neurol Sci       Date:  2012-06-30       Impact factor: 3.307

7.  T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.

Authors:  Chris J Hedegaard; Martin Krakauer; Klaus Bendtzen; Henrik Lund; Finn Sellebjerg; Claus H Nielsen
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

8.  Capturing T Lymphocytes' Dynamic Interactions With Human Neural Cells Using Time-Lapse Microscopy.

Authors:  Florent Lemaître; Ana Carmena Moratalla; Negar Farzam-Kia; Yves Carpentier Solorio; Olivier Tastet; Aurélie Cleret-Buhot; Jean Victor Guimond; Elie Haddad; Nathalie Arbour
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

9.  Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.

Authors:  Camille L Pittet; Jia Newcombe; Alexandre Prat; Nathalie Arbour
Journal:  J Neuroinflammation       Date:  2011-11-08       Impact factor: 8.322

10.  A complex role of herpes viruses in the disease process of multiple sclerosis.

Authors:  Simone C Wuest; Ina Mexhitaj; Noo Ri Chai; Elena Romm; Joerg Scheffel; Biying Xu; Kelly Lane; Tianxia Wu; Bibiana Bielekova
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.